7 trends tracked about this subject — the full history, oldest to newest below.
The US Food and Drug Administration and Health Canada have approved bepirovirsen, marketed as Hibsago, as the first functional cure for chronic hepatitis B.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A controversial US-backed hepatitis B vaccine trial involving newborns in Guinea Bissau is formally canceled amid widespread backlash.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A controversial hepatitis B vaccine trial in Guinea-Bissau advances after securing approval from a Danish university.